1887

n Cardiovascular Journal of Africa - AstraZeneca Pharmaceuticals enables scientific innovation : industry news

USD

 

Abstract

Critically aware of the need for funding that will develop research capacity and contribute to academic advancement in South Africa, ethical pharmaceutical company, AstraZeneca Pharmaceuticals, has set up a not-for-profit trust for the disbursement of medical research funding. The company will award R1.5 million a year for three years for academic research; high-level, non-interventional studies including doctoral and postdoctoral work that will generate significant data currently not available.

Loading

Article metrics loading...

/content/cardio1/25/1/EJC149284
2014-01-01
2016-12-02
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error